Mission Bay Capital
40
25M
27
2.86
4
0.33
6
- Stages of investment
- Areas of investment
Summary
In 2009 was created Mission Bay Capital, which is appeared as VC. The leading representative office of defined VC is situated in the San Francisco. The fund was located in North America if to be more exact in United States.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Mission Bay Capital, startups are often financed by OrbiMed, Polaris Partners, Topspin Partners. The meaningful sponsors for the fund in investment in the same round are OrbiMed, OUP (Osage University Partners), SR One. In the next rounds fund is usually obtained by OrbiMed, SR One, Morgenthaler Ventures.
Besides them, we counted 3 critical employees of this fund in our database.
The top activity for fund was in 2015. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. This Mission Bay Capital works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in 2-6 deals every year. The top amount of exits for fund were in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Genetics, Pharmaceutical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Alector, Bolt Threads, Caribou Biosciences.
Investments analytics
Analytics
- Total investments
- 40
- Lead investments
- 4
- Exits
- 6
- Rounds per year
- 2.86
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (33)
- Health Care (25)
- Therapeutics (21)
- Medical (9)
- Medical Device (5) Show 25 more
- Investments by region
-
- United States (38)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 75M
- Group Appearance index
- 0.88
- Avg. company exit year
- 4
- Avg. multiplicator
- 11.55
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Caribou Biosciences | 25 Mar 2015 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 11M | United States, California, Berkeley |
| QurAlis | 09 Mar 2023 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 88M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.